medicare

KeyBanc Capital’s Donald Hooker expects the Investor Summit hosted by athenahealth, Inc (NASDAQ: ATHN) on December 15 to include discussions on two “promising” verticals, hospitals and population health management. Hooker maintains a Sector Weight rating on the company....

Barclays said Laboratory Corp. of America Holdings (NYSE: LH) management noted it sees some sustainable tailwinds for volume growth in its lab business, while reimbursement visibility remains good through the end of 2017. Analysts, including Jack Meehan who had investor meetings with LabCorp...

Biotech stocks spiked higher on Wednesday after the U.S. government said that Medicare will be exhausted in 2028, two years sooner than projected last year. In addition, the U.S. government said that a cost-cutting mechanism known as the Independent Payment Advisory Board (IPAB) is projected to...

Citi started coverage of Cotiviti Holdings Inc (NYSE: COTV) with a Neutral rating and $21 price target, citing near-term risks including client M&A among its relatively concentrated customer base. "Net, we have a favorable view of the company's offerings but with an ETR of ~10%,...

Looking for another reason to dislike drug companies? Good news: Some companies systematically use charitable giving as a way to raise their drug prices with minimal public awareness. Bloomberg’s Benjamin Elgin and Robert Langreth reported on a number of cases in which drug companies seem...

Brand-name prescription drug prices have skyrocketed over the past five years, coming in twice as expensive as the prices in 2011. Express Scripts Holding Company (NASDAQ: ESRX), the United States' largest pharmacy conglomerate, compiled the data and came to the initial findings regarding...

Healthcare has been one of the best performing sectors of the U.S. stock market for years, but in 2015, shares of healthcare stocks have suffered slightly. Many investors began to worry about the impact next year's presidential election might have on the sector. Some candidates have voiced concern...

After speaking with industry insiders and legal experts, Leerink believes that the selloff in pharmaceutical stocks is overdone. Experts see “near zero odds” that Hillary Clinton’s drug pricing plan will become law without significant changes. Leerink believes that the most...

It seems everything is working in the favor of Aetna Inc (NYSE: AET) right now. The company reported very strong second-quarter numbers on Tuesday, as it prepares to complete the $37 billion Humana Inc (NYSE: HUM) acquisition. Aetna Chairman and CEO Mark Bertolini was on CNBC recently to discuss...

The health insurance industry seems to be in a takeover mania right now with all the major five players involved in one way or the other. While Aetna Inc (NYSE: AET) made an offer for Humana Inc (NYSE: HUM) recently, Anthem Inc (NYSE: ANTM) made a $184 per share takeover bid for CIGNA Corporation...

Medicare's expected enrollment growth of 50 percent in the next 15 years makes Humana Inc (NYSE: HUM) a glittering prize in the health insurance industry. But a couple of analysts diverged Monday over whether to recommend Humana as a current investment. Humana, which gets about 85 percent of its...

Exchange-traded healthcare funds were little changed Friday on a report that Humana Inc (NYSE: HUM) hired advisors to consider a sale. The Dow Jones U.S. Health Care Index closed down 1.4 percent Friday. Exchange-traded healthcare funds aim to mirror sector performance by holding a wide a mix of...

Aetna Inc (NYSE: AET) came out with better-than-expected first-quarter results on Tuesday. Operating EPS for the company came at $2.39 on revenue of $51.1 billion, versus analysts' expectations of $1.95 and $15.5 billion respectively. Ana Gupte from Leerink Partners, was on CNBC following the...